deCODE genetics, Inc.
199 articles with deCODE genetics, Inc.
-
First report from the worlds most ambitious sequencing project
7/20/2022
Scientists at deCODE genetics a subsidiary of Amgen together with collaborators from Denmark report on the whole genome sequences of 150 thousand participants in the UK biobank in a paper published in the journal Nature.
-
Decode Genetics Publishes the Largest Ever Study of the Plasma Proteome
12/2/2021
In a study published in Nature genetics, scientists at deCODE genetics, a subsidiary of the pharmaceutical company Amgen, demonstrate how measuring the levels of a large number of proteins in plasma at population scale when combined with data on sequence diversity and RNA expression dramatically increases insights into human diseases and other phenotypes.
-
deCODE genetics: Predicting the probability of death
6/18/2021
Scientists from deCODE genetics have developed a predictor based on protein measurements in blood samples that predicts the time to all-cause death better than traditional risk factors.
-
deCODE genetics - Rounding off the human genome
5/10/2021
In a study published today, scientists at deCODE Genetics demonstrate for the first time how long-read DNA sequencing can be applied at population scale to unravel large structural variants that associate with human disease and other traits.
-
There is new research out of Iceland that suggests the body’s immune response to COVID-19 lasts longer than other research has suggested.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 2, 2020.
-
Dietary cholesterol and phytosterols contribute directly to heart disease
8/6/2020
Genetic variability in cholesterol and phytosterol absorption affects cardiovascular disease risk
-
Iceland Provides a Picture of the Early Spread of COVID-19 in a Population With a Cohesive Public Health Response
4/14/2020
Study combines the most intensive targeted testing and general screening of any population to date with comprehensive sequencing of the virus from all identified cases, to trace its mutation and spread
-
Beyond Cholesterol: Landmark deCODE Study Elucidates Role of Lipoprotein(a) as Major Risk Factor for Heart Disease
12/9/2019
Highly diverse, understudied and not routinely screened for, Lp(a) -- an alipoprotein(a) bound to an LDL cholesterol particle -- may be the next most important serum risk factor after LDL itself
-
Amgen hopes the data will provide insights into specific diseases that will help develop new drugs.
-
deCODE Genetics, An Amgen Subsidiary, And SomaLogic Announce Collaboration To Perform Large-Scale Protein Analysis Of Up To 40,000 Human Samples
12/13/2018
Largest-ever Protein Measurement Study Enhances deCODE's Efforts in Basic Research, Drug Discovery and Novel Protein-based Diagnostics
-
deCODE genetics Study Reveals An Ancient Achilles Heel In The Human Genome
9/21/2017
-
deCODE genetics Release: Company Study Shows That Variants In The Sequence Of The Genome That Contribute To Educational Attainment Are Under Negative Selection
1/17/2017
-
deCODE genetics Release: Beyond LDL: Decode Population-Wide Study In Iceland Refines Understanding Of Link Between Cholesterol And Heart Disease
5/4/2016
-
Amgen's deCODE genetics Publishes Largest Human Genome Population Study
3/27/2015
-
deCODE genetics, Inc. Uncovers Impact Of Mutations In The Human Genome On Cognitive Ability
12/19/2013
-
With deCODE genetics, Inc. Deal, Amgen Aims to Discover Drugs Like We Meant to in 1999
12/11/2012
-
Amgen Bags Gene-Hunting Firm deCODE genetics, Inc. for $415 Million Cash
12/11/2012
-
New Gene Triples Risk for Alzheimer's Disease, deCODE genetics, Inc. and University College London Study
11/15/2012
-
deCODE genetics, Inc., Multinational Research Team Find Gene Variant Conferring High Risk for Common, Late-Onset Form of Alzheimer's Disease
11/15/2012